Your Mounjaro price guide · October 2026
Human GLP-1: What It Is and How Medicines Use It (October 2026)
Human GLP-1 (glucagon-like peptide-1) is a natural gut hormone that helps regulate appetite, slows how quickly the stomach empties and supports the body's response to insulin. GLP-1 medicines such as Mounjaro, Wegovy and liraglutide are prescription treatments designed to act on the same receptors. Supplements and foods are not equivalent to them. Current as of 9 October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Human GLP-1 is a natural gut hormone; GLP-1 medicines are prescription treatments that act on its receptors.
-
Mounjaro activates both GIP and GLP-1 receptors, which sets it apart from single-action medicines such as semaglutide.
-
Mounjaro is available on the NHS, but access is phased over several years; regulated private treatment is an alternative.
-
Prescription GLP-1 medicines are supplied only after a consultation reviewed by a GPhC-registered prescriber.
In this guide
01 · The core answer
What "human GLP-1" actually means
Human GLP-1 is the version of the glucagon-like peptide-1 hormone that your own body produces in the gut. It is a natural signal, not a drug, and nobody needs to "get" it from a pill or a shop: your body already makes it every time you eat. The question most readers are really asking is whether they can do something to increase it, or whether a medicine can do the job better.
The honest answer has layers. Food, sleep and activity all shape appetite, and a balanced diet is the foundation of any weight plan. But the medicines that have been tested in large trials are not simply "boosting" your own hormone. They are designed to act on the same receptors in a controlled, prescribed way, alongside a reduced-calorie diet and increased physical activity.
Mounjaro is a good example. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.1
02 · Your decision
Is this relevant to you, and what next?
If you want to know whether a medicine is an option, the key question is whether you meet the licensed criteria and whether a prescriber agrees it is appropriate.
Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes.1 NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first.4 Many people who meet the licensed criteria choose regulated private treatment rather than waiting for NHS access.
You do not have to decide today. A free online consultation is a short health questionnaire, with no charge and no obligation, and it is reviewed by a GPhC-registered prescriber. If treatment is unsuitable, any order is refunded automatically. When you are ready, the Mounjaro pen page shows live prices: the standard 2.5mg starting pen costs £169.99 per month, and new customers pay £129.99 for that first pen with code FIRST40 (a first-order price). You can also explore our wider weight loss clinic information first.
03 · The key distinction
Natural GLP-1 versus a GLP-1 medicine
The simplest way to hold the difference in your head: the hormone is the body's own message, and the medicine is a prescribed treatment built to act on the same receptors. They are related, but they are not interchangeable. A food that is said to "support" the hormone has not been tested the way a licensed medicine has, and it comes with no prescriber oversight, no monitoring and no regulated trial data.
| Question | Human GLP-1 (natural) | Licensed GLP-1 medicine |
|---|---|---|
| What is it? | A hormone your gut makes | A prescription medicine, for example Mounjaro, Wegovy or liraglutide |
| Who controls it? | Your body, in response to eating | A prescriber, with ongoing review |
| Dosing | Not something you dose | Set doses; Mounjaro comes in six strengths from 2.5mg to 15mg |
| Trial evidence for weight loss | Not applicable | Yes; for example SURMOUNT-1 for tirzepatide |
| Supplements claiming to "raise" it | — | Not comparable; dosing is not standardised |
Related guide: Glp 1 7 36.
04 · The hormone itself
What GLP-1 stands for and what the hormone does
GLP-1 stands for glucagon-like peptide-1. It is a gut hormone, which means your digestive system releases it as part of the conversation between your gut and your brain about food.
The key point is that GLP-1 is one of the natural gut-hormone receptors that medicines can activate. When that signalling is engaged, it helps regulate appetite, slows how quickly the stomach empties and improves the way the body responds to insulin.1 Those three effects are the reason the hormone attracts so much attention in both diabetes care and weight management.
Appetite regulation is the part most people notice. A slower-emptying stomach and better-regulated hunger signals can mean feeling full sooner and less hungry between meals. That does not make eating effortless, and it does not replace the need for a reduced-calorie diet and more physical activity. It simply makes those habits easier for many people to keep up.
The insulin effect explains why GLP-1 medicines were first developed for diabetes. Better insulin response is useful when blood sugar control is the goal. In the UK, Mounjaro is licensed both for weight management in adults and for type 2 diabetes.1
If you want a deeper read, our guide to GLP-1 physiology takes the biology further.
One practical reason the natural hormone is not simply used as a medicine is that treatments need to be convenient and predictable. Licensed GLP-1 medicines are designed for scheduled dosing, such as once-weekly injections for Mounjaro and Wegovy. For now, the takeaway is simple: the hormone is the biological idea, and the medicines are the engineered, tested way of using that idea.
It is also worth saying what the word "human" does not mean. It does not imply a medicine is derived from people, and it does not mean a medicine is inferior or superior because of its origin. Treatments are judged on trial results, safety information and regulatory approval, not on how closely their name resembles the hormone.
05 · How Mounjaro acts
How Mounjaro acts on GIP and GLP-1 receptors
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1 The strengths are stepped, so most people start low and move up with prescriber guidance.
What makes it distinctive is that it does not rely on GLP-1 alone. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).1
A question we hear often is whether a dual-action medicine is automatically better. That is not something to assume from the mechanism alone. Both tirzepatide and semaglutide are effective, licensed treatments; which suits you depends on your health profile, tolerance and prescriber advice, not the headline number alone. If you are choosing between them, the practical factors are your suitability, your prescriber's advice and how you tolerate the medicine.
How long does it stay in the body? Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system.
Cost-wise, the standard price of a 2.5mg pen is £169.99 per month, and if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A new customer's first order is £40 less, and every later order is £25 less than the standard price. Prices were checked 10 October 2026, and all six doses are in stock through the Mounjaro pen page.
None of this is a reason to start treatment without advice. The prescriber's review is the point where your history, current medicines and goals are considered together, and it is the step that keeps treatment appropriate rather than automatic.
06 · Other GLP-1 medicines
Other GLP-1 medicines you may hear about
Mounjaro is not the only medicine that acts on the GLP-1 pathway. Semaglutide is sold as Ozempic and Wegovy, and liraglutide is sold as Saxenda and in products such as Erly. Each has its own licence, dosing pattern and prescriber considerations, so it helps to know the basics of what separates them.
Wegovy (semaglutide) is a once-weekly injection. Its pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, and titration steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17. The 2.4mg dose is the licensed maintenance dose for weight management.18 You can see current availability and prices on the Wegovy pen page, and a first Wegovy pen is £99.99 as a first-order price.
Liraglutide is different in an important practical way: it is supplied at a concentration of 6mg per millilitre and is a daily injection, unlike once-weekly Mounjaro and Wegovy. For some people the daily routine is a downside, for others it is simply a habit.
Oral options also exist. Wegovy tablets and the tablet orforglipron (Foundayo) are covered by their own product information.
Which is the "safest" GLP-1? There is no single answer. Each licensed medicine has a documented side-effect profile, and suitability depends on the individual: other medicines you take, your medical history, whether you could become pregnant, and how you responded to earlier treatment. The safest choice is the one a prescriber has reviewed against your details, supplied from a regulated pharmacy, with a plan for follow-up.
What about switching between them? Switching between medicines is decided by a prescriber, who also decides which dose to start on; Wegovy's licensed dose ladder starts at 0.25mg. If you are moving to us from another provider at a higher dose, the new-customer discount of £40 applies to your first order at any dose, and a switch at 15mg means a first order of £289.99.
07 · Trial evidence
What the trial evidence says about tirzepatide
Mounjaro's weight-management evidence comes from the SURMOUNT-1 trial. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2
These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.2 Trial averages do not predict your own result.
The same trial reported how many people reached particular thresholds: at 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.2
To make a percentage feel real, take a worked example: for someone starting at 100 kg, 20.9% is about 21 kg.
SURMOUNT-5 is the first large head-to-head trial of tirzepatide and semaglutide for weight loss.15 Other trials, such as the semaglutide STEP 1 study or liraglutide studies, tested different people under different conditions, so their numbers should not be lined up against SURMOUNT-1 as a ranking.
Finally, think about what a trial can and cannot tell you. It tells you what happened on average to a group of people who were closely monitored, who took the medicine as directed and who followed lifestyle advice. It does not tell you how you will feel on the first few doses, how your appetite will change or whether you will find the routine easy. Your prescriber's reviews exist to answer those questions as you go.
08 · Natural and supplements
Can you raise GLP-1 naturally? Supplements, cinnamon and food
Cinnamon, berberine, fibre products and so-called "nature's Ozempic" supplements are not medicines, are not regulated for this use and have no comparable trial evidence.
Supplements are typically low-cost and available cheaply without assessment. That cheapness is part of the problem rather than a benefit: there is no clinical oversight, no review of whether the product suits you and no monitoring if something goes wrong. Dosing is not standardised, so two products with the same label can differ meaningfully. Dramatic weight-loss claims in marketing are a warning sign, not a selling point.
That does not mean food is irrelevant. A varied diet with plenty of protein and fibre-rich plant foods supports appetite and general health, and regular activity helps whatever else you do. But "helps appetite" is very different from "is a GLP-1 medicine in food form". If you are curious about a specific food, our page on extra virgin olive oil and GLP-1 goes into more detail.
Be especially wary of products that borrow the language of prescription medicines. Anyone offering to supply a GLP-1 medicine without a consultation or prescription is not operating within UK rules, and counterfeit injectable products are a real risk. The MHRA publishes counterfeit medicine alerts, and you can report suspected problems with a medicine through the Yellow Card scheme.7
Check a pharmacy before you buy. Our own registration is GPhC 9012878, and anyone can verify a UK pharmacy on the GPhC register. Genuine Mounjaro KwikPens come through official LillyDirect supply, direct from Eli Lilly's UK distribution.
The sensible plan is to see supplements and foods as, at most, minor lifestyle choices, and to treat prescription treatment as a separate, clinically supervised decision.
09 · NHS and private
Getting a GLP-1 medicine: NHS and private routes
The question "how do I get GLP-1 for weight loss?" has two honest routes in the UK: the NHS and regulated private treatment. Both require clinical assessment, and neither is available as a simple over-the-counter purchase.
On the NHS, Mounjaro is available, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).4 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
Your GP is the right first conversation if you think you may qualify. NHS access to Wegovy runs through specialist weight-management services, so ask your GP what is available locally. You can also read the NHS information and the NHS England guidance on weight management injections for the wider picture.6
Private treatment suits people who want to start sooner, or who do not fall into the current NHS groups. It is not a shortcut around safety: Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and used alongside a reduced-calorie diet and increased physical activity.
- Complete a free online consultation: a short health questionnaire, with no charge and no obligation.
- A GPhC-registered prescriber reviews it, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
- Our registered pharmacy dispenses it, with same-day dispatch when ordered by 3pm, and free next-day tracked delivery in discreet, temperature-controlled packaging. Saturday delivery is £14.99.
The consultation is free, and the price shown is the price paid, with no hidden fees. Needles, a sharps bin and injection guidance come with every order. Repeat orders re-check suitability, and there is no auto-shipping or subscription lock-in. Ongoing monthly reviews, dose-titration and follow-up assessments are handled by the prescribing team, with side-effect support if you need it.
On cost, the standard Mounjaro price runs from £169.99 for 2.5mg to £329.99 for 15mg per month. At standard prices, a first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. A new customer's first order is £40 less with code FIRST40, and every later order is £25 less (code DOSE25). Klarna and pay-monthly options are available.
10 · Safety and storage
Safety, the patient leaflet and storing your pen
Every prescription GLP-1 medicine comes with a patient information leaflet, and for Mounjaro it is published on the electronic medicines compendium.13 The leaflet covers possible side effects, who should not use the medicine, how to inject and how to store the pen. Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.
If you notice a symptom that is not listed, do not assume it is related or unrelated: discuss any new symptom with your prescriber, and report suspected side effects through the Yellow Card scheme.19
Two interaction points are worth knowing. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.1 And if you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. That is a conversation to have with your prescriber, not a reason to change anything yourself.
Storage is practical and worth getting right. Keep unopened pens in the fridge, at 2–8°C, until first use; they keep until the printed expiry date. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen.1 If an unopened pen has been left out of the fridge, check the patient information leaflet and contact the pharmacy rather than guessing.
Follow the pen's instructions for injecting, and use the sharps bin supplied with your order. If something arrives faulty, damaged or the wrong item, contact us within three days, as dispensed prescription medicines cannot otherwise be returned.
Stopping treatment is not an emergency. After a final dose the medicine clears over roughly four to five weeks, and nothing needs doing while that happens. Talk to your prescriber about what to expect with appetite and how to keep supporting your routine. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413.
This page is information, not a substitute for medical advice. Individual results vary.
11 · Research and context
How long GLP-1 has been studied and where it is heading
Tirzepatide's weight-management evidence includes SURMOUNT-1 over 72 weeks.2 The SURMOUNT-4 trial looked at continued treatment for maintenance of weight reduction, a reminder that this is a longer-term approach rather than a quick fix.14 The semaglutide STEP 1 trial is the equivalent landmark for Wegovy.
The practical lesson from the research is about expectations. These medicines work alongside a reduced-calorie diet and increased physical activity. Results vary from person to person. Some people respond strongly, some modestly, and tolerability differs. A good treatment plan includes regular reviews so that dose and approach can be adjusted.
There is also a wider story about how quickly these medicines have moved from specialist use to everyday conversation. Our page on GLP-1 adoption looks at that shift, and our GLP-1 investment page covers the commercial side.
Medicines in development matter too, though they should be treated carefully. Newer agents are being studied, and the oral GLP-1 tablets that are now licensed have their own product information. Anything still unlicensed in the UK is not something a pharmacy can supply, and a seller offering it should be treated with suspicion. Stick to products with a UK licence and a prescriber behind them.
If you have read this far and think a medicine may be relevant, a sensible next step is a free consultation.
For service details, our weight management information sits in the weight loss clinic section, and more than 100,000 customers have been supported on their weight loss journey, with free tracking through the GLPTrackr companion app on iOS and Android.
12 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1 Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat does GLP-1 stand for?
What is human GLP-1?
How can I get GLP-1 naturally?
Is there a natural GLP-1 supplement that works for weight loss?
Is there a cinnamon GLP-1 human study?
What is the safest GLP-1 to take?
How do I get GLP-1 for weight loss in the UK?
What information is in the GLP-1 patient information leaflet?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 9 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


